Pharmarise HoldingsPharmarise Holdings Corporation2796東証スタンダードサービス業FY ending May 2026, consolidated, J-GAAP

Pharmarise Holdings FY ending May 2020 results

About 79% of Pharmarise Holdings's sales come from Dispensing pharmacy, with Cosmetic,drug and convenience store and Custody of medical documents making up much of the rest.

Out of every ¥100 of sales, about ¥2 is left as operating profit.

Where the money goes

Where ¥100 of sales goes

For every ¥100 Pharmarise Holdings sells, how much goes where, and how much is kept.

FY ending May 2020

Cost of sales: ¥85
SG&A: ¥13
Operating profit: ¥2
Net profit kept: ¥1

Margin funnel (derived from reported values)Gross margin 14.6% → Operating margin 2.0% → Net margin 1.1%

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending May 2020

Dispensing pharmacy¥40.4B
79%
Op. margin 3.3%Industry: Drugstores & Pharmacies
Cosmetic,drug and convenience store¥8.82B
17%
Op. margin -1.5%Industry: Convenience Stores
Custody of medical documents¥667M
1%
Op. margin 10.8%Industry: Business Process Outsourcing
Other¥623M
1%
Op. margin -1.0%
Medical mall¥505M
1%
Op. margin 14.5%Industry: Real Estate Development & Leasing

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (3)

EDINET (FSA Japan)
有価証券報告書－第38期(2023/06/01－2024/05/31)
ID S100UB272024-08-30Open
EDINET (FSA Japan)
有価証券報告書－第36期(令和3年6月1日－令和4年5月31日)
ID S100P3F92022-08-26Open
EDINET (FSA Japan)
有価証券報告書－第35期(令和2年6月1日－令和3年5月31日)
ID S100MCTA2021-08-27Open

Extracted from XBRL: 49 / Derived from other figures: 2

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open Markdown Share on X Save image